1032998-24-5
1032998-24-5
Chemical Structure
N-Acetylneuraminic acid-13C-1
Synonym(s): NANA-13C-1;Lactaminic acid-13C-1
- CAS No.: 1032998-24-5
- Formula:C1013CH19NO9
- Molecular Weight:310.26
IUPAC Name: (4S,5R,6R,7S,8R)-5-acetamido-4,6,7,8,9-pentahydroxy-2-oxononanoic-2-13C acid
InChIKey: KBGAYAKRZNYFFG-MFOUSPHQSA-N
SMILES: OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](NC(C)=O)[C@@H](O)C[13C](C(O)=O)=O
Biological Activity: N-Acetylneuraminic acid-13C-1 is the 13C labeled N-Acetylneuraminic acid.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
N-Acetylneuraminic acid-13C-1 | N-Acetylneuraminic acid-13C-1 is the 13C labeled N-Acetylneuraminic acid. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
N-Acetylneuraminic acid (Standard) | 99.86% | N-Acetylneuraminic acid (Standard) is the analytical standard of N-Acetylneuraminic acid. This product is intended for research and analytical applications. N-Acetylneuraminic acid (NANA; Lactaminic acid), a nonphenolic structure, is the predominant form of sialic from Collocalia esculenta. N-Acetylneuraminic acid plays a biological role in myocardial injury, melanoma and viral or bacterial infection. N-Acetylneuraminic acid inhibits melanogenesis by reducing tyrosinase activity and triggers myocardial injury in vitro and in vivo by activation of the Rho/Rho-associated signaling pathway through binding to RhoA and Cdc42. N-Acetylneuraminic acid may prevent high fat diet (HFD)-induced inflammation and oxidative stress, thereby prevents hyperlipidemia-associated inflammation and oxidative stress. N-Acetylneuraminic acid is promising for research in the field of melanoma, coronary artery, obesity-related diseases and hyperlipidemia. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
N-Acetylneuraminic acid-13C-2 | N-Acetylneuraminic acid-13C-2 is the 13C labeled N-Acetylneuraminic acid. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
N-Acetylneuraminic acid-13C-3 | 99.0% | N-Acetylneuraminic acid-13C-3 is the 13C labeled N-Acetylneuraminic acid. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
N-Acetylneuraminic acid-13C | N-Acetylneuraminic acid-13C is the 13C labeled N-Acetylneuraminic acid. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
N-Acetylneuraminic acid | 99.95% | N-Acetylneuraminic acid (NANA; Lactaminic acid), a nonphenolic structure, is the predominant form of sialic from Collocalia esculenta. N-Acetylneuraminic acid plays a biological role in myocardial injury, melanoma and viral or bacterial infection. N-Acetylneuraminic acid inhibits melanogenesis by reducing tyrosinase activity and triggers myocardial injury in vitro and in vivo by activation of the Rho/Rho-associated signaling pathway through binding to RhoA and Cdc42. N-Acetylneuraminic acid may prevent high fat diet (HFD)-induced inflammation and oxidative stress, thereby prevents hyperlipidemia-associated inflammation and oxidative stress. N-Acetylneuraminic acid is promising for research in the field of melanoma, coronary artery, obesity-related diseases and hyperlipidemia. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
